HCV Treatment Immune Response With Grazoprevir/Elbasvir Before or After Renal Transplant

NCT02902120 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis C
Renal Insufficiency, Chronic
Disorder of Transplanted Kidney

Interventions

DRUG: Post-transplant Grazoprevir and Elbasvir

Sponsor

University of Maryland, Baltimore